Duncan McKechnie, EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,633 shares at $498.42 ($1.3M) on 2026-03-11, disclosed to the SEC on 2026-03-13.
Open-market sale of $1.3M VRTX by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VRTX | SELL | 2026-02-26 | $2.4M | — | Filing → |